{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:25:26Z","timestamp":1787714726919,"version":"build-2784847793"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>It has become increasingly clear that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect most organs in the human body, including the neurologic and ophthalmic systems. Vaccination campaigns have been developed at rapid pace around the world to protect the population from the fast-mutating virus. This review seeks to summarise current knowledge of the neuro-ophthalmic manifestations of both COVID-19 infection and vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Evidence acquisition<\/jats:title><jats:p>Electronic searches for published literature were conducted using EMBASE and MEDLINE on the 30<jats:sup>th<\/jats:sup> of July 2023. The search strategy comprised of controlled vocabulary and free-text synonyms for the following terms in various combinations: \u201ccoronavirus, COVID-19, SARS-CoV-2, 2019-nCoV, vaccination, vaccine, immunisation and neuro-ophthalmology\u201d. No time range limits were set for the literature search. Published English abstracts for articles written in a different language were screened if available.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 54 case reports and case series were selected for use in the final report. 34 articles documenting neuro-ophthalmic manifestations following COVID-19 infection and 20 articles with neuro-ophthalmic complications following COVID-19 vaccination were included, comprising of 79 patients in total. The most commonly occurring condition was optic neuritis, with 25 cases following COVID-19 infection and 27 cases following vaccination against COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The various COVID-19 vaccines that are currently available are part of the global effort to protect the most vulnerable of the human population. The incidence of neuro-ophthalmic consequences following infection with COVID-19 is hundred-folds higher and associated with more harrowing systemic effects than vaccination against the virus.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1345683","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:41:32Z","timestamp":1705466492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination"],"prefix":"10.3389","volume":"14","author":[{"given":"Jane","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3174\/ajnr.A7134","article-title":"Cerebral venous thrombosis in COVID-19: A New York metropolitan cohort study","volume":"42","author":"Al-Mufti","year":"2021","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1007\/s10072-021-05832-9","article-title":"Bilateral optic neuritis after COVID vaccination","volume":"43","author":"Arnao","year":"2022","journal-title":"Neurol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1097\/WNO.0000000000001469","article-title":"Raised intracranial pressure (pseudotumour cerebri) associated with severe acute respiratory syndrome coronavirus 2","volume":"42","author":"Balendra","year":"2022","journal-title":"J. Neuroophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/09273948.2020.1792512","article-title":"Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19)","volume":"28","author":"Benito-Pascual","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.yaoo.2021.04.017","article-title":"Neuro-ophthalmologic manifestations of novel coronavirus","volume":"6","author":"Betsch","year":"2021","journal-title":"Adv. Ophthalmol. Optom."},{"key":"B8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.survophthal.2022.09.003","article-title":"Shot in the dark","volume":"68","author":"Bhatti","year":"2023","journal-title":"Surv. Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jfo.2021.04.002","article-title":"Optic neuropathy in a COVID-19 patient","volume":"44","author":"Borrego-Sanz","year":"2021","journal-title":"J. Fr. Ophtalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"578011","DOI":"10.1016\/j.jneuroim.2022.578011","article-title":"Atypical myelin oligodendrocyte glycoprotein antibody\u2013associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review","volume":"375","author":"Bosello","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease","volume":"77","author":"Braithwaite","year":"2020","journal-title":"JAMA Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/WNO.0000000000001364","article-title":"Myelin oligodendrocyte glycoprotein and neuromyelitis optica\/aquaporin-4 antibody negative COVID-19-associated optic neuritis","volume":"43","author":"Caudill","year":"2023","journal-title":"J. Neuroophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.survophthal.2021.04.001","article-title":"Ocular adverse events following vaccination: overview and update","volume":"67","author":"Cheng","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e16791","DOI":"10.7759\/cureus.16791","article-title":"Tolosa-Hunt syndrome presenting after COVID-19 vaccination","volume":"13","author":"Chuang","year":"2021","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e931665","DOI":"10.12659\/AJCR.931665","article-title":"Unilateral optic neuritis associated with SARS-CoV-2 infection: A rare complication","volume":"22","author":"Deane","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"Np49","DOI":"10.1177\/11206721221077800","article-title":"Post-COVID simultaneous onset of Graves\u2019 disease and ocular myasthenia gravis in a patient with a complex ocular motility impairment","volume":"33","author":"De Giglio","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1097\/WNO.0000000000001229","article-title":"Orbital inflammation with optic perineuritis in association with COVID-19","volume":"42","author":"Dinkin","year":"2022","journal-title":"J. Neuroophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jfo.2022.09.005","article-title":"Optic neuritis after COVID-19 infection: A case report","volume":"46","author":"Duran","year":"2023","journal-title":"J. Fr. Ophtalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/00207454.2021.2015348","article-title":"Optic neuropathy after COVID-19 vaccination: a report of two cases","volume":"133","author":"Elnahry","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"577939","DOI":"10.1016\/j.jneuroim.2022.577939","article-title":"Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review","volume":"371","author":"Feizi","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3174\/ajnr.A6595","article-title":"Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection","volume":"41","author":"Franceschi","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamaophthalmol.2020.5695","article-title":"Coronavirus disease 2019\u2013associated ocular neuropathy with panuveitis: A case report","volume":"139","author":"Fran\u00e7ois","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ana.26339","article-title":"Neurological events reported after COVID-19 vaccines: An analysis of VAERS","volume":"91","author":"Frontera","year":"2022","journal-title":"Ann. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13073-021-00933-8","article-title":"Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19","volume":"13","author":"Fullard","year":"2021","journal-title":"Genome Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"Np87","DOI":"10.1177\/11206721221136319","article-title":"MOG-IgG positive optic neuritis after SARS-CoV-2 infection","volume":"33","author":"Gilardi","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26065","article-title":"ANA Investigates: Neurological complications of COVID-19 vaccines","volume":"89","author":"Goss","year":"2021","journal-title":"Ann. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2313","DOI":"10.1002\/rmv.2313","article-title":"Covid-19 vaccines and variants of concern: A review","volume":"32","author":"Hadj Hassine","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00415-021-10647-x","article-title":"Acute bilateral optic\/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2","volume":"269","author":"Helmchen","year":"2022","journal-title":"J. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1111\/ene.14965","article-title":"Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: Case series and literature review","volume":"28","author":"Hixon","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","article-title":"SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: A case report and literature review","volume":"61","author":"Ide","year":"2022","journal-title":"Intern. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"Np168","DOI":"10.1177\/1120672120947591","article-title":"Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state","volume":"32","author":"Insausti-Garc\u00eda","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1007\/s00415-022-11194-9","article-title":"MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature","volume":"269","author":"Jarius","year":"2022","journal-title":"J. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/acn3.51609","article-title":"SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder","volume":"9","author":"Johnsson","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/ijo.IJO_2235_21","article-title":"COVID-19-associated optic neuritis - A case series and review of literature","volume":"70","author":"Jossy","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s10072-023-06715-x","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis following third dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus erythematosus","volume":"44","author":"Kang","year":"2023","journal-title":"Neurol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/01658107.2022.2037661","article-title":"Inflammatory sixth nerve palsy post-COVID-19 vaccination: Magnetic resonance imaging findings","volume":"46","author":"Karam","year":"2022","journal-title":"Neuroophthalmology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"198114","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 Vaccine: A comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"116858","DOI":"10.1016\/j.jns.2020.116858","article-title":"Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report","volume":"413","author":"Kaya","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1017\/cjn.2021.129","article-title":"Idiopathic intracranial hypertension associated with SARS-CoV-2 B.1.1.7 variant of concern","volume":"49","author":"Khalid","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"116943","DOI":"10.1016\/j.jns.2020.116943","article-title":"Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19","volume":"414","author":"Kishfy","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.1097\/WNO.0000000000001347","article-title":"Antiaquaporin 4-related optic neuritis and myelitis post-COVID-19 infection","volume":"42","author":"Kivanany","year":"2022","journal-title":"J. Neuroophthalmol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e25865","DOI":"10.1097\/MD.0000000000025865","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report","volume":"100","author":"Kogure","year":"2021","journal-title":"Med. (Baltimore)."},{"key":"B47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/v12080880","article-title":"Of mice and men: The Coronavirus MHV and mouse models as a translational approach to understand SARS-CoV-2","volume":"12","author":"K\u00f6rner","year":"2020","journal-title":"Viruses"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/09273948.2021.1961815","article-title":"Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: A case report","volume":"29","author":"Leber","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/qjmed\/hcac208","article-title":"COVID-19 vaccine-associated optic neuritis","volume":"115","author":"Lee","year":"2022","journal-title":"Qjm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/21645515.2020.1804777","article-title":"SARS-CoV-2 vaccine candidates in rapid development","volume":"17","author":"Li","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/WNO.0000000000001537","article-title":"Neuro-ophthalmological complications of the COVID-19 vaccines: A systematic review","volume":"42","author":"Lotan","year":"2022","journal-title":"J. Neuroophthalmol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/EB.S268828","article-title":"A review of neuro-ophthalmological manifestations of human coronavirus infection","volume":"12","author":"Lu\u00eds","year":"2020","journal-title":"Eye Brain."},{"key":"B54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat. Hum. Behav."},{"key":"B55","doi-asserted-by":"publisher","first-page":"23247096231186046","DOI":"10.1177\/23247096231186046","article-title":"Bilateral optic neuritis and hypophysitis with diabetes insipidus 1 month after COVID-19 mRNA vaccine: Case report and literature review","volume":"11","author":"Matsuo","year":"2023","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1017\/cjn.2021.183","article-title":"Optic neuritis associated with SARS-CoV-2 B.1.1.7 variant of concern","volume":"49","author":"Micieli","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1210\/clinem\/dgac606","article-title":"New onset or deterioration of thyroid eye disease after mRNA SARS-CoV-2 vaccines: Report of 2 cases and literature review","volume":"108","author":"Mohamed","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1097\/WNO.0000000000001467","article-title":"Pseudotumor cerebri syndrome with COVID-19: A case series","volume":"42","author":"Mukharesh","year":"2022","journal-title":"J. Neuroophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12883-022-02575-8","article-title":"Acute disseminated encephalomyelitis with bilateral optic neuritis following ChAdOx1 COVID-19 vaccination","volume":"22","author":"Nagaratnam","year":"2022","journal-title":"BMC Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","article-title":"Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac \u2013 PROFISCOV: A structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"Np46","DOI":"10.1177\/11206721221118736","article-title":"Optic neuritis following COVID-19 vaccination: Do autoimmune diseases play a role","volume":"33","author":"Pirani","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3390\/healthcare10081422","article-title":"Effect of COVID-19 lockdowns on eye emergency department, increasing prevalence of uveitis and optic neuritis in the COVID-19 era","volume":"10","author":"Przybek-Skrzypecka","year":"2022","journal-title":"Healthcare (Basel)."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1016\/j.jfo.2022.02.019","article-title":"Idiopathic intracranial hypertension as a neurological manifestation of COVID-19: A case report","volume":"45","author":"Rajabi","year":"2022","journal-title":"J. Fr. Ophtalmol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"173751","DOI":"10.1016\/j.ejphar.2020.173751","article-title":"COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies","volume":"892","author":"Rawat","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s13365-021-00959-z","article-title":"Optic neuritis following SARS-CoV-2 infection","volume":"27","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2021","journal-title":"J. Neurovirol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"679","DOI":"10.4103\/ijo.IJO_2374_21","article-title":"Optic neuritis following COVID-19 vaccination: Coincidence or side-effect? - A case series","volume":"70","author":"Roy","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.4103\/ijo.IJO_2155_21","article-title":"Acute bilateral retrobulbar optic neuritis - an atypical sequela of COVID-19","volume":"69","author":"Sainath","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2324709620976018","DOI":"10.1177\/2324709620976018","article-title":"COVID-19-induced acute bilateral optic neuritis","volume":"8","author":"Sawalha","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4103\/ijo.IJO_3666_20","article-title":"Unilateral inferior altitudinal visual field defect related to COVID-19","volume":"69","author":"Sharma","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/WNO.0000000000001811","article-title":"Optic neuritis after SARS-CoV-2 vaccination","volume":"43","author":"Shemer","year":"2023","journal-title":"J. Neuroophthalmol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1128\/JVI.00920-08","article-title":"Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus","volume":"82","author":"Shindler","year":"2008","journal-title":"J. Virol."},{"key":"B75","article-title":"Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination","volume":"93","author":"Shukla","year":"2022","journal-title":"Monaldi Arch. Chest Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s12098-021-03921-3","article-title":"Optic neuritis as a presenting symptom of post-COVID-19 multisystem inflammatory syndrome in children (MIS-C)","volume":"88","author":"Sinha","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"B77","doi-asserted-by":"publisher","first-page":"101684","DOI":"10.1016\/j.ajoc.2022.101684","article-title":"Non-arteritic anterior ischemic optic neuropathy in COVID-19 infection - A case report","volume":"27","author":"Sitaula","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmab075","article-title":"Pseudotumor cerebri syndrome as a neurologic involvement of multisystem inflammatory syndrome in children: A case report","volume":"67","author":"Sofuo\u011flu","year":"2021","journal-title":"J. Trop. Pediatr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/brainsci12030407","article-title":"COVID-19 vaccination and neurological manifestations: A review of case reports and case series","volume":"12","author":"Sriwastava","year":"2022","journal-title":"Brain Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava","year":"2021","journal-title":"J. Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.autrev.2013.03.012","article-title":"A literature review on optic neuritis following vaccination against virus infections","volume":"12","author":"St\u00fcbgen","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","article-title":"Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1\u2008284\u2008437 patients","volume":"9","author":"Taquet","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1097\/WNO.0000000000001232","article-title":"Optic nerve infarction in a patient with Coronavirus disease 2019","volume":"42","author":"Tavakoli","year":"2022","journal-title":"J. Neuroophthalmol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","article-title":"Acute disseminated encephalomyelitis","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/WNO.0000000000001276","article-title":"Afferent and efferent neuro-ophthalmic complications of coronavirus disease 19","volume":"41","author":"Tisdale","year":"2021","journal-title":"J. Neuroophthalmol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/practneurol-2021-003194","article-title":"Posterior reversible encephalopathy syndrome (PRES): diagnosis and management","volume":"22","author":"Triplett","year":"2022","journal-title":"Pract. Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0140-6736(20)31725-6","article-title":"Pseudotumor cerebri syndrome associated with MIS-C: a case report","volume":"396","author":"Verkuil","year":"2020","journal-title":"Lancet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1038\/s41433-020-1069-8","article-title":"Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection","volume":"34","author":"Virgo","year":"2020","journal-title":"Eye (Lond)."},{"key":"B89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"B90","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2021.11.029","article-title":"Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management","volume":"95","author":"Wang","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10633-022-09880-0","article-title":"Unilateral optic neuritis after vaccination against the coronavirus disease: two case reports","volume":"145","author":"Wang","year":"2022","journal-title":"Doc. Ophthalmol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/ceo.14221","article-title":"An eye to the future: Acute and long-term neuro-ophthalmological and neurological complications of COVID-19","volume":"51","author":"Wesselingh","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B93","article-title":"COVID-19 vaccine tracker and landscape","year":"2023"},{"key":"B94","article-title":"WHO Coronavirus (COVID-19) dashboard","year":"2023"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/s41591-022-02001-z","article-title":"Long-term neurologic outcomes of COVID-19","volume":"28","author":"Xu","year":"2022","journal-title":"Nat. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","article-title":"Dysregulation of brain and choroid plexus cell types in severe COVID-19","volume":"595","author":"Yang","year":"2021","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.4103\/ijo.IJO_2494_21","article-title":"Aquaporin-4 protein antibody-associated optic neuritis related to neuroendocrine tumor after receiving an inactive COVID-19 vaccine","volume":"70","author":"Y\u0131ld\u0131z Tasc\u0131","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12886-023-02825-4","article-title":"Hyperacute optic neuritis in a patient with COVID-19 infection and vaccination: a case report","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Ophthalmol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ophtha.2023.08.021","article-title":"Optic neuritis and cranial neuropathies diagnosis rates before coronavirus disease 2019, in the initial pandemic phase, and post-vaccine introduction","volume":"131","author":"Zhao","year":"2024","journal-title":"Ophthalmology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/WNO.0000000000001049","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"J. Neuroophthalmol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1345683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:41:35Z","timestamp":1705466495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1345683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":100,"alternative-id":["10.3389\/fcimb.2024.1345683"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1345683","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"article-number":"1345683"}}